Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04837209
Title Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer (NADiR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital

triple-receptor negative breast cancer


Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sibley Memorial Hospital Recruiting Washington District of Columbia 20016 United States Details
Massachusetts General Hospital Cancer Center Recruiting Boston Massachusetts 02114 United States Details
University of North Carolina Medical Center Not yet recruiting Chapel Hill North Carolina 27514 United States Details
*Shaded cells indicate that there was no data available from for the field